TG Therapeutics Inc (TGTX)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 566,359 | 317,943 | 168,274 | 330,965 | 611,740 |
| Total current liabilities | US$ in thousands | 90,679 | 53,720 | 53,201 | 65,384 | 87,554 |
| Current ratio | 6.25 | 5.92 | 3.16 | 5.06 | 6.99 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $566,359K ÷ $90,679K
= 6.25
TG Therapeutics Inc's current ratio has shown a declining trend over the past five years. The ratio decreased from 6.99 on December 31, 2020, to 5.06 on December 31, 2021, indicating a reduction in the company's ability to meet its short-term obligations with its current assets. This declining trend continued through December 31, 2022, with the current ratio further decreasing to 3.16. However, there was an improvement in the company's liquidity position by December 31, 2023, where the current ratio increased to 5.92, suggesting an enhancement in the company's ability to cover its current liabilities with current assets. By December 31, 2024, the current ratio further improved to 6.25, indicating a strengthened liquidity position compared to the previous year. Overall, the fluctuations in the current ratio reflect changes in the company's short-term liquidity management over the five-year period.
Peer comparison
Dec 31, 2024